Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank100
3Y CAGR+45.5%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+45.5%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
3.1x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$677.56M+60.1%
2024$423.24M+56.6%
2023$270.26M+22.7%
2022$220.18M+471.2%
2021$38.54M-
2020$0.00-
2019$0.00-
2018$0.00-
2017$0.00-
2016$0.00-